Trump Signs Executive Order to Reclassify Marijuana, Major Boost for Cannabis Industry
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Fool
- Policy Shift: On December 18, 2025, President Trump signed an executive order to reclassify marijuana from Schedule I to Schedule III, marking a significant shift in U.S. cannabis policy in over 50 years, which may accelerate the legalization process.
- Tax Relief: The reclassification exempts companies like Green Thumb, Tilray, and Trulieve from IRS Code Section 280E, allowing them to deduct business expenses such as payroll and rent, which is expected to significantly enhance profit margins.
- Access to Financial Services: This policy change could improve cannabis companies' access to financial services, as banks may become more willing to work with them, facilitating industry financing and expansion.
- Investment Appeal: The reclassification is likely to attract more investors to cannabis stocks, with Tilray already announcing plans to expand its U.S. medical cannabis operations, reflecting a positive market response to the policy change.
TLRY
$10.42+Infinity%1D
Analyst Views on TLRY
Wall Street analysts forecast TLRY stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for TLRY is 4.45 USD with a low forecast of 0.85 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
2 Buy
0 Hold
1 Sell
Moderate Buy
Current: 11.160
Low
0.85
Averages
4.45
High
10.00
Current: 11.160
Low
0.85
Averages
4.45
High
10.00
About TLRY
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
